Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Analysis of Short-term (Operating) Activity Ratios

Microsoft Excel

Short-term Activity Ratios (Summary)

Turnover Ratios

Average No. Days

Edwards Lifesciences Corp., short-term (operating) activity ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Turnover Ratios
Inventory turnover 1.72 1.35 1.74 1.55 1.58
Receivables turnover 8.99 8.52 8.00 8.15 8.15
Payables turnover 6.11 5.50 6.18 7.01 7.51
Working capital turnover 2.44 2.00 2.09 2.64 3.04
Average No. Days
Average inventory processing period 212 271 210 236 231
Add: Average receivable collection period 41 43 46 45 45
Operating cycle 253 314 256 281 276
Less: Average payables payment period 60 66 59 52 49
Cash conversion cycle 193 248 197 229 227

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


An analysis of short-term operating activity from 2017 to 2021 reveals a period of fluctuation with a significant disruption in 2020, followed by a marked improvement in efficiency by the end of 2021. The company's operational liquidity is heavily influenced by a prolonged inventory cycle, though improvements in receivable collections and strategic payables management have mitigated some of the associated cash flow pressures.

Inventory Management
Inventory turnover has remained relatively low, fluctuating between 1.35 and 1.74. A notable decline occurred in 2020, where the turnover ratio dropped to 1.35 and the average inventory processing period peaked at 271 days. However, by 2021, the turnover ratio recovered to 1.72, reducing the processing period to 212 days, the lowest level in the five-year period.
Receivables Management
A consistent trend of improving efficiency is observed in the collection of receivables. The receivables turnover ratio increased from 8.15 in 2017 to 8.99 in 2021. Correspondingly, the average receivable collection period decreased from 45 days to 41 days, indicating a more streamlined credit-to-cash process.
Payables Management
There is a general trend toward extending the average payables payment period, which rose from 49 days in 2017 to a peak of 66 days in 2020, before settling at 60 days in 2021. This is reflected in the payables turnover ratio, which decreased from 7.51 to 6.11 over the period, suggesting a strategic shift to retain cash longer by extending payment terms to suppliers.
Working Capital and Cash Conversion Cycle
Working capital turnover experienced a downward trend from 3.04 in 2017 to a low of 2.00 in 2020, before rebounding to 2.44 in 2021. The operating cycle and cash conversion cycle (CCC) both mirrored the volatility of inventory levels. The CCC peaked at 248 days in 2020 but improved significantly to 193 days by 2021. This reduction in the CCC indicates that the company has become more efficient at converting its investments in inventory and receivables back into cash.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Inventory Turnover

Edwards Lifesciences Corp., inventory turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Cost of sales 1,248,900 1,080,600 1,114,400 939,400 875,300
Inventories 726,700 802,300 640,900 607,000 554,900
Short-term Activity Ratio
Inventory turnover1 1.72 1.35 1.74 1.55 1.58
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 3.59 — — — —
Intuitive Surgical Inc. 2.98 — — — —
Medtronic PLC 2.43 — — — —
Inventory Turnover, Sector
Health Care Equipment & Services 31.85 — — — —
Inventory Turnover, Industry
Health Care 7.90 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Inventory turnover = Cost of sales ÷ Inventories
= 1,248,900 ÷ 726,700 = 1.72

2 Click competitor name to see calculations.


The financial trajectory from 2017 to 2021 indicates a general expansion in both cost of sales and inventory levels. Cost of sales experienced a steady upward trend, rising from US$ 875.3 million in 2017 to US$ 1,248.9 million by 2021, despite a minor contraction occurring in 2020. Simultaneously, inventory holdings increased from US$ 554.9 million to US$ 726.7 million over the same period, though a notable peak was reached in 2020 at US$ 802.3 million.

Inventory Turnover Volatility
The inventory turnover ratio exhibited fluctuations throughout the five-year period, reflecting varying levels of operational efficiency. After remaining relatively stable between 2017 and 2018, the ratio peaked at 1.74 in 2019, indicating an acceleration in the rate at which inventory was utilized to generate sales.
Operational Slowdown in 2020
A significant decline in turnover efficiency occurred in 2020, with the ratio dropping to 1.35. This downturn coincided with a simultaneous increase in inventory levels and a decrease in the cost of sales, suggesting a slower rate of inventory depletion and a potential buildup of unsold stock during that fiscal year.
Efficiency Recovery in 2021
By the end of 2021, inventory turnover rebounded to 1.72. This recovery was driven by a substantial increase in the cost of sales to US$ 1,248.9 million and a strategic reduction in inventory holdings to US$ 726.7 million, effectively restoring turnover efficiency to levels observed in 2019.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Receivables Turnover

Edwards Lifesciences Corp., receivables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Net sales 5,232,500 4,386,300 4,348,000 3,722,800 3,435,300
Accounts receivable, net of allowances 582,200 514,600 543,600 456,900 421,600
Short-term Activity Ratio
Receivables turnover1 8.99 8.52 8.00 8.15 8.15
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 6.64 — — — —
Elevance Health Inc. 20.66 — — — —
Intuitive Surgical Inc. 7.30 — — — —
Medtronic PLC 5.51 — — — —
UnitedHealth Group Inc. 20.07 — — — —
Receivables Turnover, Sector
Health Care Equipment & Services 14.76 — — — —
Receivables Turnover, Industry
Health Care 8.00 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Receivables turnover = Net sales ÷ Accounts receivable, net of allowances
= 5,232,500 ÷ 582,200 = 8.99

2 Click competitor name to see calculations.


An analysis of short-term operating activity reveals a consistent expansion in net sales and a corresponding improvement in the efficiency of receivables collection over the five-year period ending December 31, 2021.

Net Sales Growth
Net sales exhibited a continuous upward trajectory, increasing from 3,435,300 thousand US dollars in 2017 to 5,232,500 thousand US dollars by 2021. This growth indicates a strong expansion in revenue generation, with a particularly significant increase observed between 2020 and 2021.
Accounts Receivable Trends
Accounts receivable, net of allowances, generally increased in alignment with the growth in sales, rising from 421,600 thousand US dollars in 2017 to 582,200 thousand US dollars in 2021. A deviation from this trend occurred in 2020, where receivables decreased to 514,600 thousand US dollars despite a marginal increase in net sales, suggesting a period of accelerated collection or a tightening of credit terms.
Receivables Turnover Efficiency
The receivables turnover ratio remained stable during the first three years of the period, fluctuating slightly between 8.00 and 8.15. A positive shift is observed starting in 2020, with the ratio increasing to 8.52 and further rising to 8.99 in 2021. This upward trend signifies that the company has improved its ability to collect outstanding receivables relative to its sales volume, resulting in a shorter cash conversion cycle and enhanced liquidity management.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Payables Turnover

Edwards Lifesciences Corp., payables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Cost of sales 1,248,900 1,080,600 1,114,400 939,400 875,300
Accounts payable 204,500 196,500 180,400 134,000 116,600
Short-term Activity Ratio
Payables turnover1 6.11 5.50 6.18 7.01 7.51
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories 4.21 — — — —
Elevance Health Inc. 7.59 — — — —
Intuitive Surgical Inc. 14.45 — — — —
Medtronic PLC 4.98 — — — —
UnitedHealth Group Inc. 7.63 — — — —
Payables Turnover, Sector
Health Care Equipment & Services 7.18 — — — —
Payables Turnover, Industry
Health Care 5.84 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Payables turnover = Cost of sales ÷ Accounts payable
= 1,248,900 ÷ 204,500 = 6.11

2 Click competitor name to see calculations.


The financial data reveals a general expansion in both the cost of sales and accounts payable over the five-year period from 2017 to 2021. While cost of sales experienced a slight contraction in 2020, the overall trajectory remained upward, increasing from 875.3 million to 1.25 billion. Concurrently, accounts payable demonstrated a consistent annual increase, rising from 116.6 million in 2017 to 204.5 million by the end of 2021.

Payables Turnover Velocity
A progressive decline in the payables turnover ratio was observed from 2017 through 2020, falling from 7.51 to 5.50. This trend indicates a lengthening of the average payment period to suppliers, suggesting that the company effectively increased its use of trade credit to finance operations during this interval.
Operational Shift in 2021
The downward trend in turnover reversed in 2021, with the ratio increasing to 6.11. This shift reflects a relative acceleration in the payment of obligations compared to the 2020 low, potentially resulting from changes in supplier terms or a strategic decision to reduce outstanding liabilities.
Correlation Between Payables and Costs
The growth in accounts payable outpaced the growth in cost of sales for the majority of the analyzed period. This divergence explains the compression of the turnover ratio, as the liability balance grew at a higher rate than the volume of purchases passing through the cost of sales account.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Working Capital Turnover

Edwards Lifesciences Corp., working capital turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in thousands)
Current assets 3,180,700 3,091,000 2,984,000 2,286,900 2,532,100
Less: Current liabilities 1,032,300 893,900 902,400 876,600 1,402,900
Working capital 2,148,400 2,197,100 2,081,600 1,410,300 1,129,200
 
Net sales 5,232,500 4,386,300 4,348,000 3,722,800 3,435,300
Short-term Activity Ratio
Working capital turnover1 2.44 2.00 2.09 2.64 3.04
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 3.87 — — — —
Elevance Health Inc. 7.23 — — — —
Intuitive Surgical Inc. 1.22 — — — —
Medtronic PLC 2.15 — — — —
UnitedHealth Group Inc. — — — — —
Working Capital Turnover, Sector
Health Care Equipment & Services 16.28 — — — —
Working Capital Turnover, Industry
Health Care 8.57 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Working capital turnover = Net sales ÷ Working capital
= 5,232,500 ÷ 2,148,400 = 2.44

2 Click competitor name to see calculations.


Net sales grew consistently between 2017 and 2021, increasing from US$ 3,435,300 thousand to US$ 5,232,500 thousand. During the same period, working capital followed an upward trajectory, rising from US$ 1,129,200 thousand in 2017 to a peak of US$ 2,197,100 thousand in 2020, before slightly contracting to US$ 2,148,400 thousand in 2021.

Working Capital Turnover Trend
The working capital turnover ratio exhibited a sustained decline from 3.04 in 2017 to a low of 2.00 in 2020. This trend indicates that the growth in working capital outpaced the growth in net sales over this four-year interval, suggesting a reduction in the efficiency with which short-term assets were utilized to generate revenue.
Operational Efficiency Recovery
A positive inflection point occurred in 2021, as the turnover ratio increased to 2.44. This recovery was driven by a combination of significant growth in net sales and a marginal decrease in working capital, reflecting an improvement in the company's ability to generate sales relative to its investment in operating liquidity.

Overall, the period was characterized by an initial decline in asset turnover efficiency that culminated in 2020, followed by a notable improvement in 2021. This suggests a transition from a phase of aggressive working capital accumulation to a more optimized phase of operational utilization.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Average Inventory Processing Period

Edwards Lifesciences Corp., average inventory processing period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data
Inventory turnover 1.72 1.35 1.74 1.55 1.58
Short-term Activity Ratio (no. days)
Average inventory processing period1 212 271 210 236 231
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 102 — — — —
Intuitive Surgical Inc. 122 — — — —
Medtronic PLC 150 — — — —
Average Inventory Processing Period, Sector
Health Care Equipment & Services 11 — — — —
Average Inventory Processing Period, Industry
Health Care 46 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 1.72 = 212

2 Click competitor name to see calculations.


The analysis of inventory activity ratios between 2017 and 2021 reveals a fluctuating pattern in operational efficiency, characterized by a significant disruption in 2020 followed by a strong recovery in 2021.

Inventory Turnover
The turnover ratio demonstrated moderate stability between 2017 and 2018, before improving to 1.74 in 2019. A significant contraction occurred in 2020, where the ratio fell to a five-year low of 1.35. This downward trend was reversed in 2021, with the ratio rebounding to 1.72, nearly returning to the peak efficiency levels observed in 2019.
Average Inventory Processing Period
The duration required to process inventory showed a corresponding inverse relationship with turnover. Following a slight increase to 236 days in 2018, the period improved to 210 days in 2019. A substantial spike was recorded in 2020, with the processing period extending to 271 days, representing a peak in inventory holding time. By 2021, the period decreased sharply to 212 days, indicating a restoration of inventory movement velocity.

Overall, the data indicates that the operational efficiency of inventory management was compromised during the 2020 fiscal year, resulting in slower turnover and an extended processing cycle. The subsequent metrics for 2021 suggest a successful correction, as both the turnover ratio and the processing period returned to levels consistent with the 2019 performance benchmarks.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Average Receivable Collection Period

Edwards Lifesciences Corp., average receivable collection period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data
Receivables turnover 8.99 8.52 8.00 8.15 8.15
Short-term Activity Ratio (no. days)
Average receivable collection period1 41 43 46 45 45
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 55 — — — —
Elevance Health Inc. 18 — — — —
Intuitive Surgical Inc. 50 — — — —
Medtronic PLC 66 — — — —
UnitedHealth Group Inc. 18 — — — —
Average Receivable Collection Period, Sector
Health Care Equipment & Services 25 — — — —
Average Receivable Collection Period, Industry
Health Care 46 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 8.99 = 41

2 Click competitor name to see calculations.


The analysis of operating activity ratios from 2017 to 2021 indicates a positive trajectory in the efficiency of receivable management. After a period of relative stability, there is a clear improvement in the speed at which credit sales are converted into cash.

Receivables Turnover
The turnover ratio remained nearly constant between 2017 and 2019, fluctuating minimally between 8.00 and 8.15. However, a distinct upward trend emerged in the subsequent two years, rising to 8.52 in 2020 and reaching a peak of 8.99 by the end of 2021. This increase suggests an acceleration in the frequency with which receivables are collected throughout the annual cycle.
Average Receivable Collection Period
The collection period mirrored the turnover trend inversely. After holding steady at 45 days in 2017 and 2018 and experiencing a marginal increase to 46 days in 2019, the collection timeframe decreased to 43 days in 2020 and further to 41 days in 2021. This reduction of five days from the 2019 peak demonstrates improved credit control and collection efficacy.

The convergence of an increasing turnover ratio and a declining collection period indicates a strengthening of the short-term liquidity position. The acceleration of cash inflows from customers suggests more stringent credit policies or more efficient collection processes, thereby reducing the amount of working capital tied up in accounts receivable.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Operating Cycle

Edwards Lifesciences Corp., operating cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data
Average inventory processing period 212 271 210 236 231
Average receivable collection period 41 43 46 45 45
Short-term Activity Ratio
Operating cycle1 253 314 256 281 276
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 157 — — — —
Intuitive Surgical Inc. 172 — — — —
Medtronic PLC 216 — — — —
Operating Cycle, Sector
Health Care Equipment & Services 36 — — — —
Operating Cycle, Industry
Health Care 92 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 212 + 41 = 253

2 Click competitor name to see calculations.


The operating cycle exhibited significant volatility over the five-year period, characterized by a distinct spike in 2020 followed by a sharp contraction in 2021. The overall duration of the cycle is heavily influenced by inventory management rather than the collection of receivables, as the latter remained relatively constant.

Average Inventory Processing Period
This metric demonstrates a non-linear trend, fluctuating between a minimum of 210 days in 2019 and a maximum of 271 days in 2020. The substantial increase observed in 2020 suggests a temporary slowdown in inventory turnover or a strategic buildup of stock. However, a significant recovery occurred by December 31, 2021, with the period decreasing to 212 days, indicating improved inventory efficiency.
Average Receivable Collection Period
The collection period remained remarkably stable throughout the analyzed timeframe, hovering between 41 and 46 days. A slight downward trend is observable from 2019 to 2021, where the period decreased from 46 days to 41 days. This suggests a consistent and slightly improving efficiency in converting accounts receivable into cash.
Operating Cycle
The total operating cycle closely mirrors the movements of the inventory processing period. After remaining relatively stable between 2017 and 2018, the cycle dropped to 256 days in 2019 before peaking at 314 days in 2020. By the end of 2021, the operating cycle reached its lowest point of the five-year period at 253 days, reflecting a more streamlined transition from initial inventory investment to cash realization.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Average Payables Payment Period

Edwards Lifesciences Corp., average payables payment period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data
Payables turnover 6.11 5.50 6.18 7.01 7.51
Short-term Activity Ratio (no. days)
Average payables payment period1 60 66 59 52 49
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Abbott Laboratories 87 — — — —
Elevance Health Inc. 48 — — — —
Intuitive Surgical Inc. 25 — — — —
Medtronic PLC 73 — — — —
UnitedHealth Group Inc. 48 — — — —
Average Payables Payment Period, Sector
Health Care Equipment & Services 51 — — — —
Average Payables Payment Period, Industry
Health Care 63 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 6.11 = 60

2 Click competitor name to see calculations.


The analysis of short-term operating activity ratios reveals a consistent trend of lengthening payment cycles from 2017 through 2020, followed by a partial reversal in 2021. This progression indicates a strategic shift in the management of supplier obligations and working capital over the five-year period.

Payables Turnover
A general downward trend is observed from 2017 to 2020, with the ratio declining from 7.51 to 5.50. This decrease indicates that accounts payable were settled less frequently during this interval. However, this trend reversed in 2021, as the turnover ratio increased to 6.11, suggesting a more accelerated pace of payment compared to the previous year.
Average Payables Payment Period
The duration required to settle obligations to suppliers expanded steadily from 49 days in 2017 to a peak of 66 days in 2020. This extension of the payment window suggests an increase in the utilization of supplier credit to support liquidity. In 2021, the period contracted to 60 days, reflecting a reduction in the average time taken to pay vendors.

The inverse correlation between the turnover ratio and the payment period confirms a period of expanding liability management through 2020. The subsequent shift in 2021 suggests a correction in payment behavior, resulting in a shortened cash conversion cycle relative to the 2020 peak.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Cash Conversion Cycle

Edwards Lifesciences Corp., cash conversion cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data
Average inventory processing period 212 271 210 236 231
Average receivable collection period 41 43 46 45 45
Average payables payment period 60 66 59 52 49
Short-term Activity Ratio
Cash conversion cycle1 193 248 197 229 227
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories 70 — — — —
Intuitive Surgical Inc. 147 — — — —
Medtronic PLC 143 — — — —
Cash Conversion Cycle, Sector
Health Care Equipment & Services -15 — — — —
Cash Conversion Cycle, Industry
Health Care 29 — — — —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 212 + 41 – 60 = 193

2 Click competitor name to see calculations.


The analysis of short-term operating activity from 2017 to 2021 reveals significant volatility in the cash conversion cycle, primarily driven by fluctuations in inventory management. While receivable collections remained stable and payables were generally extended, the overall liquidity cycle is characterized by a lengthy period of capital tie-up in inventory.

Average Inventory Processing Period
This metric exhibits the highest degree of variance among the analyzed ratios. Following a slight increase in 2018, the period decreased to 210 days in 2019, before peaking at 271 days in 2020. A substantial correction occurred in 2021, returning the period to 212 days. The 2020 peak suggests a temporary buildup of stock or a deceleration in turnover, which significantly extended the cash cycle during that fiscal year.
Average Receivable Collection Period
Collection efficiency remained remarkably consistent throughout the five-year period. The duration fluctuated minimally between 41 and 46 days, with a gradual improvement observed from 2019 through 2021. This stability indicates a disciplined approach to credit terms and effective accounts receivable management.
Average Payables Payment Period
A steady increase in the payment period was observed from 2017 (49 days) to 2020 (66 days), suggesting a strategic effort to leverage supplier credit to optimize working capital. This trend reversed slightly in 2021, with the period settling at 60 days.
Cash Conversion Cycle
The overall cash conversion cycle mirrored the volatility of inventory processing. The cycle peaked at 248 days in 2020 and reached its lowest point of 193 days in 2021. The substantial length of the cycle underscores the heavy reliance on inventory movement to release cash.

In summary, operational efficiency is heavily contingent upon inventory turnover. The stability in receivable collections and the strategic extension of payables serve as mitigating factors, but the significant inventory holding period remains the dominant influence on the short-term liquidity position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?